Carfilzomib Intravenous and Onasemnogene abeparvovec Zolgensma
Determining the interaction of Carfilzomib Intravenous and Onasemnogene abeparvovec Zolgensma and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carfilzomib
Brand name: Kyprolis
Synonyms: Carfilzomib
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma), Onasemnogene Abeparvovec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carfilzomib Intravenous-Oncaspar
- Carfilzomib Intravenous-Oncovin
- Carfilzomib Intravenous-Ondansetron
- Carfilzomib Intravenous-Ondansetron and Dextrose
- Carfilzomib Intravenous-Ondansetron Hydrochloride
- Carfilzomib Intravenous-Ondansetron injection
- Onasemnogene abeparvovec Zolgensma-Carimene N/F
- Onasemnogene abeparvovec Zolgensma-Carimune IGIV
- Onasemnogene abeparvovec Zolgensma-Carimune NF
- Onasemnogene abeparvovec Zolgensma-Cariprazine
- Onasemnogene abeparvovec Zolgensma-Cariprazine Hydrochloride
- Onasemnogene abeparvovec Zolgensma-Carisoprodol